Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹1,163 Cr₹1,809 Cr₹867 Cr₹903 Cr₹807 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,163 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹1,163 Cr
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr
Mar2021₹807 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹1,163 Cr
-35.72
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr
11.87
Mar2021 ₹807 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹75,283.3 Cr 4% 13.1% 19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4%

13.1%

19.7%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses